Ocular manifestations of psoriasis

We aimed to report the ocular manifestations observed in patients with psoriasis. Patients were included and referred to our ophthalmology clinic from dermatology clinics of Universidade do Estado do Pará between October 2013 and August 2014. Clinical interviews were conducted to identify relevant e...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos brasileiros de oftalmologia Vol. 81; no. 3; pp. 219 - 225
Main Authors: Cruz, Natasha Ferreira Santos da, Brandão, Larissa Silva, Cruz, Sérgio Ferreira Santos da, Cruz, Sérgio Augusto Sequeira da, Pires, Carla Andréa Avelar, Carneiro, Francisca Regina Oliveira
Format: Journal Article
Language:English
Published: Brazil Conselho Brasileiro de Oftalmologia 01-06-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to report the ocular manifestations observed in patients with psoriasis. Patients were included and referred to our ophthalmology clinic from dermatology clinics of Universidade do Estado do Pará between October 2013 and August 2014. Clinical interviews were conducted to identify relevant epidemiological data, clinical features, and treatment details, and data were recorded using the same protocol. Subsequent dermatological examinations were performed and disease severity was rated using the Psoriasis Area and Severity Index and the Dermatological Life Quality Index. Complete eye examination was conducted, including visual acuity, biomicroscopy, tonometry, fundoscopy, Schirmer I test, tear breakup time, rose bengal staining, ocular surface disease index, and glaucoma tests. In total, we included 43 patients with psoriasis and 86 controls. Patients with psoriasis had statistically higher incidences of dry eye (16.28%), likely dry eye (32.56%), and blepharitis (16.28%). Furthermore, the rose bengal and ocular surface disease tests were more abnormal in patients with psoriasis (p<0.05). Patients with psoriasis should undergo regular eye exams, regardless of risk factors, to monitor for the progression of symptomatic or asymptomatic ocular manifestations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0004-2749
1678-2925
1678-2925
DOI:10.5935/0004-2749.20180044